Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
International Journal of Environmental Research and Public Health
|
February 15, 2022
Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare
Denis Horgan, Bettina Borisch, Ivana Cattaneo, et al.
Hemasphere
|
March 26, 2025
Two distinct fetal-type signatures characterize juvenile myelomonocytic leukemia
Marion Strullu, Chloé Arfeuille, Aurélie Caye-Eude, et al.
Blood
|
February 11, 2003
CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD
Fotini Nicolaou, Jens M Teodoridis, Heiyoung Park, et al.
Cancer Research
|
September 19, 2007
Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?
Feyruz V Rassool, Terry J Gaymes, Nader Omidvar, et al.
Molecular Pharmacology
|
June 22, 2019
T-Cell Protein Tyrosine Phosphatase Is Irreversibly Inhibited by Etoposide-Quinone, a Reactive Metabolite of the Chemotherapy Drug Etoposide
Qing Nian, Jérémy Berthelet, Wenchao Zhang, et al.
Blood Cancer Journal
|
October 6, 2018
Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo
Emmanuelle Verger, Juliette Soret-Dulphy, Nabih Maslah, et al.
Nature
|
September 3, 2015
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
Stéphane Prost, Francis Relouzat, Marc Spentchian, et al.
Blood
|
October 23, 2008
Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia
Anne Saumet, Guillaume Vetter, Manuella Bouttier, et al.
Blood
|
October 22, 2015
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations
Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau, et al.
Biochemical Pharmacology
|
November 6, 2003
Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib (Gleevec) in vitro and in vivo
Jérôme Larghero, Thibaut Leguay, Samia Mourah, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
International Journal of Environmental Research and Public Health
|
February 15, 2022
Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare
Denis Horgan, Bettina Borisch, Ivana Cattaneo, et al.
Hemasphere
|
March 26, 2025
Two distinct fetal-type signatures characterize juvenile myelomonocytic leukemia
Marion Strullu, Chloé Arfeuille, Aurélie Caye-Eude, et al.
Blood
|
February 11, 2003
CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD
Fotini Nicolaou, Jens M Teodoridis, Heiyoung Park, et al.
Cancer Research
|
September 19, 2007
Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?
Feyruz V Rassool, Terry J Gaymes, Nader Omidvar, et al.
Molecular Pharmacology
|
June 22, 2019
T-Cell Protein Tyrosine Phosphatase Is Irreversibly Inhibited by Etoposide-Quinone, a Reactive Metabolite of the Chemotherapy Drug Etoposide
Qing Nian, Jérémy Berthelet, Wenchao Zhang, et al.
Blood Cancer Journal
|
October 6, 2018
Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo
Emmanuelle Verger, Juliette Soret-Dulphy, Nabih Maslah, et al.
Nature
|
September 3, 2015
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
Stéphane Prost, Francis Relouzat, Marc Spentchian, et al.
Blood
|
October 23, 2008
Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia
Anne Saumet, Guillaume Vetter, Manuella Bouttier, et al.
Blood
|
October 22, 2015
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations
Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau, et al.
Biochemical Pharmacology
|
November 6, 2003
Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib (Gleevec) in vitro and in vivo
Jérôme Larghero, Thibaut Leguay, Samia Mourah, et al.
Page
of 11